Improving analysis of functional imaging

Target mutations in lung cancer

Utilisation of older and newer agents in treating mantle cell lymphoma

Immunotherapy for the elderly

Multiple myeloma in the elderly

New optimism for advanced breast cancer patients failing antiestrogens: Opening audience survey

Biology and function of CDKs

Clinical data on breast cancer trials

CDK 4/6 inhibitors: Management of side effects

History of antiangiogenic drugs in multiple myeloma, starting with thalidomide

How can we make the best decisions for health whilst considering cost?

Coming of age for CDK 4/6 inhibitors: Welcome and interactive session